KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Hims & Hers Health (HIMS) EPS (Weighted Average and Diluted) (2019 - 2026)

Hims & Hers Health's EPS (Weighted Average and Diluted) history spans 8 years, with the latest figure at -$0.4 for Q1 2026.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 300.0% to -$0.4 in Q1 2026 year-over-year; TTM through Mar 2026 was -$0.09, a 113.24% decrease, with the full-year FY2025 number at $0.51, down 3.77% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$0.4 in Q1 2026 for Hims & Hers Health, down from $0.08 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for HIMS hit a ceiling of $0.32 in Q3 2024 and a floor of -$0.4 in Q1 2026.
  • Historically, EPS (Weighted Average and Diluted) has averaged $0.01 across 5 years, with a median of $0.01 in 2023.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): surged 900.0% in 2024 and later plummeted 300.0% in 2026.
  • Tracing HIMS's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.05 in 2022, then soared by 120.0% to $0.01 in 2023, then surged by 900.0% to $0.1 in 2024, then dropped by 20.0% to $0.08 in 2025, then tumbled by 600.0% to -$0.4 in 2026.
  • Business Quant data shows EPS (Weighted Average and Diluted) for HIMS at -$0.4 in Q1 2026, $0.08 in Q4 2025, and $0.06 in Q3 2025.